Nisarga Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 08-08-2024
- Paid Up Capital ₹ 1.50 Cr
as on 08-08-2024
- Company Age 26 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.40 Cr
as on 08-08-2024
- Satisfied Charges ₹ 15.58 Cr
as on 08-08-2024
- Revenue 6.27%
(FY 2023)
- Profit 1.67%
(FY 2023)
- Ebitda -6.65%
(FY 2023)
- Net Worth 18.06%
(FY 2023)
- Total Assets 19.40%
(FY 2023)
About Nisarga Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹4.40 Cr. The company has closed loans amounting to ₹15.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
Girish Soman, Jalindar Shinde, Devendra Soman, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24119PN1998PTC114090
- Company No.
114090
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 1998
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Satara, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Nisarga Biotech?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Soman  | Director | 27-Jul-2000 | Current |
| Devendra Soman | Director | 23-Sep-2019 | Current |
| Jalindar Shinde | Director | 27-Jul-2000 | Current |
| Tanmay Soman | Director | 28-May-2022 | Current |
| Shantanu Shinde | Director | 23-Feb-2022 | Current |
| Arati Soman | Director | 29-Sep-2023 | Current |
Financial Performance of Nisarga Biotech.
Nisarga Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.27% increase. The company also saw a slight improvement in profitability, with a 1.67% increase in profit. The company's net worth Soared by an impressive increase of 18.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nisarga Biotech?
In 2023, Nisarga Biotech had a promoter holding of 50.00% and a public holding of 50.00%. The company had 5 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nisarga Healthcare Private LimitedActive 16 years 8 monthsGirish Soman, Jalindar Shinde and 2 more are mutual person
Sanvardhini Agro Pvt LtdActive 31 years 7 monthsGirish Soman, Jalindar Shinde and 3 more are mutual person
- Krushitek Private LimitedActive 24 years 6 months
Girish Soman, Jalindar Shinde and 3 more are mutual person
- Sonark Pharmaceutical Private LimitedActive 36 years 3 months
Girish Soman, Jalindar Shinde and 5 more are mutual person
Charges (Loans)
₹4.40 Cr
₹15.58 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 4.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2024 | Hdfc Bank Limited | ₹2.60 Cr | Open |
| 09 Jan 2023 | Hdfc Bank Limited | ₹1.80 Cr | Open |
| 11 Apr 2018 | Hdfc Bank Limited | ₹2.75 Cr | Satisfied |
| 09 Apr 2018 | Hdfc Bank Limited | ₹5.64 Cr | Satisfied |
| 05 Jan 2018 | Hdfc Bank Limited | ₹2.89 Cr | Satisfied |
How Many Employees Work at Nisarga Biotech?
Nisarga Biotech has a workforce of 55 employees as of Aug 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nisarga Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nisarga Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
